S. Morell‐Dubois

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

J. B. Kuemmerle‐Deschner, É. Hachulla, R. Cartwright et al. · Annals of the Rheumatic Diseases · 2011 · 217 citations

Medicine, Dermatology, Pharmacology +12

Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.

É. Hachulla, Pierre Clerson, David Launay et al. · PubMed · 2007 · 212 citations

Medicine, Immunology, Internal Medicine +13

High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome

M. Lambert, David Launay, É. Hachulla et al. · Critical Care Medicine · 2008 · 122 citations

Life Sciences, Immunology, Internal Medicine +6

Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.

David Launay, Luc Mouthon, É. Hachulla et al. · PubMed · 2007 · 120 citations

Medicine, Clinical Sciences, Internal Medicine +16

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease

N. Le Gouellec, Alain Duhamel, T. Pérez et al. · PLoS ONE · 2017 · 105 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16